Check-Cap Initiated the US Pivotal Trial for C-Scan®
On May 11, 2022, Check-Cap Ltd., a clinical-stage diagnostic company initiated the US pivotal trial for C-Scan® at Mayo Clinic in Rochester Minnesota. C-Scan is the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC). The company has obtained the Institutional review board (IRB) approval for the study and is anticipating to promptly begin the patient enrolment. The principal investigator of the study will be Elizabeth Rajan, M.D., gastroenterologist, and professor of medicine at Mayo Clinic.
About the trial:
The US pivotal ...
